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1,5-Di(4-amidinophenoxy)pentane (pentamidine) and 38 analogs of pentamidine were screened for in vitro
activity against the enteric pr-otozoan Giardia lamblia WB (ATCC 30957). All compounds were active against
G. lamblia as measured by a [methyl-3Hlthymidine incorporation assay. Antigiardial activity varied widely,
with 50% inhibitory concentrations (IC50s) ranging from 0.51 ± 0.13 ,uM (mean + standard deviation) for the
most active compound to over 100.0 ,tM for the least active compounds. The IC50 of the most potent
antigiardial agent, 1,3-di(4-amidino-2-methoxyphenoxy)propane compared favorably with the IC50s of the
compounds currently used to treat giardiasis, i.e., furazolidone (1.0 ± 0.03 ,uM), metronidazole (2.1 ± 0.80
,tM), quinacrine HCI (0.03 ± 0.02 ,uM), and tinidazole (0.78 + 0.48 ,uM). A mode of antigiardial activity for
these compounds was suggested by the correlation observed between antigiardial activity and the binding of the
compounds to calf thymus DNA and poly(dA) . poly(dT).
Giardia lamblia (also known as G. intestinalis) is an
important cause of acute and chronic gastrointestinal disease
throughout the world and has been identified as the etiologic
agent in numerous waterborne outbreaks of diarrheal dis-
ease. Although G. lamblia is among the most prevalent
enteric protozoal infections in humans, it is relatively re-
cently that improvements in the in vitro cultivation of this
organism have allowed reliable, reproducible tests to assess
the in vitro activity of therapeutic agents against G. lamblia
(3, 19, 21). The agents currently used to treat giardiasis,
furazolidone, metronidazole, quinacrine HCI, and tinida-
zole, were developed for treatment of other infections and
were empirically discovered to be effective against G. lam-
blia (3, 21). Treatment failures and undesirable side effects
have been reported following the use of all four of these
compounds (6, 29, 45). Thus, there is a need for more
effective and less toxic antigiardial agents. In this report, we
show that G. lamblia is susceptible to dicationic molecules
and that the antigiardial activities of some of the more potent
pentamidine analogs compare favorably with those of agents
presently used to treat this infection.
Aromatic diamidines have been used clinically since their
antiprotozoal actiyity was first noted in the 1930s by inves-
tigators searching for agents with activity against African
trypanosomiasis (24). Several parasitic organisms have been
reported to be susceptible to aromatic diamidines, including
Acanthamoeba sp. (1, 26), Babesia sp. (13, 31), Crithidia
fasciculata (16, 44), Leishmania sp. (2, 25, 36, 39), Plasmo-
dium sp. (2, 8, 14), Pneumocystis carinii (20,22, 39, 41, 42),
and Trypanosoma sp. (17, 18, 30, 39). In addition to anti-
parasitic activity, these compounds have also been reported
to exhibit antibacterial (11), antiviral (43), antifungal (11),
and antitumor (27) activities. Traditionally, aromatic dia-
midines, particularly pentamidine, have been used to treat
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African trypanosomiasis (17, 18, 30, 39), antimony-resistant
leishmaniasis (4, 39), and more recently, P. carinii pneumo-
nia (10, 20, 35, 39). The recent increase in life-threatening P.
carinii pneumonia in patients with the acquired immune
deficiency syndrome has resulted in a revived interest in
pentamidine and related derivatives. Although pentamidine
has been used for decades, little is known about its mecha-
nism(s) of action.
The broad spectrum of activity exhibited by aromatic
diamidines and the strongly basic nature of the molecules
have hindered efforts to determine the mechanism(s) by
which they exert their activity. Many different mechanisms
have been proposed to explain the antimicrobial activities
of pentamidine and related compounds. A single mechanism
of action may not be responsible for the action of aro-
matic diamidines against microorganisms. Additionally, the
mode(s) of action of this class of compounds may differ from
one organism to another. It has been suggested that these
compounds interfere with nucleic acid synthesis and/or
metabolism (16, 40, 44). Pentamidine and other diamidines,
such as 4',6-diamidino-2-phenylindole and berenil, have
been shown to bind to DNA and exhibit a preference for
binding to A+T-rich regions in the minor groove of B-DNA
(12, 28, 32, 34, 38). To assess their range of activity further
and better understand the mechanism(s) of antimicrobial
action, we examined the structure-activity relationships of
pentamidine and 38 analogs of pentamidine in an in vitro
assay against G. lamblia WB (ATCC 30957) and correlated
the antigiardial activities of these dicationic molecules with
their DNA-binding affinities.
MATERIALS AND METHODS
Chemotherapeutic agents. Pentamidine and the 38 analogs
of pentamidine used in this study were synthesized as mono-
and dihydrochloride salts in the laboratories of Richard R.
Tidwell, Department of Pathology, School of Medicine,
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University of North Carolina at Chapel Hill. Syntheses were
carried out by previously described methods (41, 42). High-
performance liquid chromatography, elemental analyses and
nuclear magnetic resonance spectroscopy were used to
determine the purity of the compounds. Quinacrine HCI,
furazolidone, metronidazole, and tinidazole were purchased
from Sigma (St. Louis, Mo.).
Axenic culture of G. lamblia trophozoites. G. lamblia WB
(ATCC 30957) was grown in filter-sterilized TYI-S-33 me-
dium supplemented with bile (23) and containing 10% heat-
inactivated fetal bovine serum, 10 jig of ampicillin (Sigma)
per ml, and 10 ,ug of gentamicin sulfate (Sigma) per ml. Stock
cultures of trophozoites were grown in screw-cap borosili-
cate glass tubes (13 by 100 mm) at 37°C. Organisms were
subcultured every 72 h by chilling the culture tube in an ice
water bath for 5 min. The trophozoites were dislodged from
the glass by inverting the chilled tube vigorously. The
number of organisms per milliliter was determined, and 5 x
104 organisms from a logarithmically growing culture were
transferred into fresh medium.
Microculture and parasite growth. The relationship be-
tween uptake of [methyl-3H]thymidine and parasite growth
was examined to validate the radiometric assay (3, 19). G.
lamblia trophozoites were grown to early log phase in
filter-sterilized TYI-S-33 medium supplemented with bile
and containing 10% fetal bovine serum. The used medium
was aspirated from the tube and replaced with assay medium
consisting of TYI-S-33 medium with bile, which was further
modified by reducing the amounts of fetal bovine serum,
Trypticase peptone (Becton Dickinson Microbiology Sys-
tems, Cockeysville, Md.), and yeast extract by 50% to
reduce nonspecific binding of strongly polar compounds to
medium components. The tubes were chilled, and the num-
bers of organisms per milliliter were determined. Logarith-
mically growing trophozoites (2.5 x 104) in assay medium
were placed into the wells of 96-well microtiter plates. To
one-half of the wells was added 1.5 ,uCi of [methyl-3H]thy-
midine per well (1 to 10 Ci/mmol). The plates were gassed
with nitrogen and incubated at 37°C for 4 to 72 h. The growth
of the trophozoites in the microtiter plates was determined
by microscopic counts by using a hemacytometer to deter-
mine the number of trophozoites per milliliter. Organisms
incubated in the presence. of [methyl-3H]thymidine were
harvested with a multimash-type cell harvester onto glass
microfiber paper by vigorous washing with ice-cold deion-
ized water. Washed and dried filters were placed into scin-
tillation vials and counted to determine [methyl-3H]thymi-
dine uptake.
Drug susceptibility testing. Serial dilutions of dicationic
compounds, furazolidone, metronidazole, quinacrine HCl,
and tinidazole in assay medium were prepared in duplicate
rows of 96-well microtiter plates. The plates were gassed
with nitrogen and incubated at 37°C. After 24 h, [methyl-3H]
thymidine was added to yield 1.5 ,uCi per well. At 42 h, the
cells were harvested and [methyl-3H]thymidine uptake was
determined. The antigiardial activities of metronidazole,
pentamidine (compound 4), and 1,3-di(4-amidino-2-methoxy-
phenoxy)propane (DAMP) (compound 16) were also exam-
ined by visual microscopic counts to confirm the validity of
the use of a radiometric assay to screen compounds for
antigiardial activity. Four sets of serial dilutions were made
for each compound in experiments comparing cell numbers
with [methyl-3Hjthymidine uptake.
DNA-binding assay. Binding of pentamidine analogs to calf
thymus DNA (Worthington Biochemicals, Freehold, N.J.),
poly(dA) * poly(dT) (Boehringer Mannheim Biochemicals,
Indianapolis, Ind.), and poly(dG-dC) - poly(dG-dC) (Phar-
macia-LKB Biotechnology, Inc., Piscataway, N.J.) was
evaluated by using a thermal denaturation assay which
measures the temperature at which drug-DNA complexes
denature. This assay allows calculation of the change in the
midpoint (ATm) of the thermal denaturation curve of calf
thymus DNA, poly(dA) poly(dT), and poly(dG-dC) - poly
(dG-dC). The binding constant of the compounds under the
same conditions is approximately proportional to the mag-
nitude of ATm (°C). This procedure has been described
previously in detail (5).
Analysis of data. Data on [methyl-3H]thymidine uptake
were fitted to a logistic-logarithmic concentration-response
function by a nonlinear regression method by using software
developed for use with an IBM-AT computer, and drug
concentrations required to inhibit 50% incorporation of
[methyl-3H]thymidine (IC50s) were determined (9, 37). Sta-
tistical analysis of data on in vitro antigiardial activity was
performed on data from two separate determinations, each
of which consisted of duplicate serial dilutions of each
compound, to obtain the mean + the standard deviation.
Because of the large number of compounds presented, it was
impossible to screen all of the compounds in duplicate at a
single time. The results, measured in counts per minute, are
therefore interpreted as percent control. A coefficient of
determination (r2) was generated for each concentration-
response curve used to determine the IC50. Data were
acceptable if r2 was .0.90. Pentamidine was used as a
control in each of the six experiments to confirm the repro-
ducibility of the assay.
The data concerning the DNA binding of the compounds
also represent the mean ± the standard deviation from two
to four separate determinations for each compound. The
multiple regression analyses to determine the correlations
between DNA-binding affinity and antigiardial activity used
these mean values. Simple linear regression analysis was
used to examine the relationship - between trophozoite
growth and [methyl-3H]thymidine uptake in the absence and
presence of test compounds. Statistical analyses were per-
formed by using the StatView 512+ software package
(Brainpower, Inc., Calabasas, Calif.) on a Macintosh II
microcomputer. The ClogP values were obtained by using
MedChem Software 3.5 (Daylight Chemical Information
System, New Orleans, La.).
RESULTS
Parasite growth. [methyl-3H]thymidine uptake by G. lam-
blia trophozoites grown in microtiter plates correlated di-
rectly with trophozoite growth determined microscopically
(Fig. 1). A highly significant positive correlation (r2 = 0.98,
P = 0.0001) was confirmed by linear regression analysis.
Drug susceptibility. The validity of the use of a radiometric
assay to screen compounds for antigiardial activity was
confirmed by comparing the growth of G. lamblia trophozo-
ites as determined by microscopic counts and [methyl-3H]
thymidine uptake in the presence of test agents (Fig. 2).
Linear regression analyses reveal significant correlations
between trophozoite growth and [methyl-3Hlthymidine up-
take in the presence of metronidazole (Fig. 2A) (r2 = 0.94, P
= 0.0001), pentamidine (Fig. 2B) (r2 = 0.91, P = 0.0001), and
1,3-di(4-amidino-2-methoxyphenoxy)propane (DAMP) (Fig.
2C) (r2 = 0.82, P = 0.0003).
The in vitro antigiardial activities of compounds currently
used to treat giardiasis, i.e., furazolidone, metronidazole,
quinacrine HCI, and tinidazole, were compared with those of
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FIG. 1. Graphic representation of the relationship between G.
lamblia growth as determined by visual counting with a hemacy-
tometer (0) and [3H]thymidine uptake (0). Each point represents
the mean of six replicates ± the standard deviation. A highly
significant positive correlation (rd = 0.98, P = 0.0001) was confirmed
by linear regression.
the most potent dicationic agents identified in this study
(Table 1). The IC50s of the most potent dicationic agents
compared favorably with those of furazolidone (1.0 ± 0.03
puM) (mean + standard deviation), metronidazole (2.1 + 0.80
,uM), quinacrine HCl (0.03 ± 0.02 ,uM), and tinidazole (0.78
± 0.48 ,uM) (Table 1).
Pentamidine and 38 analogs of pentamidine were tested for
activity against G. lamblia and affinity for calf thymus DNA,
poly(dA) poly(dT), and poly(dG-dC) poly(dG-dC). These
data are arranged in tabular form (Tables 2 to 6) on the basis
of homogeneous structural modifications. The structure of
pentamidine was altered by (i) variation of the length of the
alkyl chain connecting the amidinophenoxy moieties from
two to six carbons (Table 2), (ii) alteration of the position of
the amidino group on the aromatic rings from a position para
to the ether bridge to the meta position (Table 3), (iii)
placement of substituent groups on the aromatic rings in
positions ortho to the ether linkage (Table 4), (iv) isosteric
replacement of the ether oxygens with nitrogens (Table 5),
and (v) replacement of the amidino groups with imidazolino
moieties (Table 6).
Pentamidine and each of the 38 analogs of pentamidine
tested exhibited in vitro activity against G. lamblia WB. The
antigiardial activities of these dicationic molecules varied
widely, with IC50s ranging from 0.51 ± 0.13 to over 100 ,uM
for some of the less potent compounds. The parent com-
pound, pentamidine (compound 4), was used as a control in
each experiment to ensure reproducibility and was found to
be very active against G. lamblia, having an IC50 of 8.5 ± 2.7
,uM (n = 6). Propamidine (compound 2), the three-carbon
analog of pentamidine, had an IC50 of 1.7 ± 0.37 ,uM and was
one of the three most potent compounds tested in this study.
The remaining two compounds which exhibited the greatest
antigiardial activity also had alkyl chains of three carbons.
The most potent dicationic molecule identified in this study
was DAMP (compound 16), in which methoxy groups have
been placed on the aromatic rings in positions ortho to the
ether linkage. Likewise, the three-carbon methoxy-substi-
tuted compound in which the amidino groups were replaced
with imidazolino moieties, 1,3-di(4-imidazolino-2-methoxy-
phenoxy)propane (DIMP) (compound 35), exhibited excel-
lent activity against G. lamblia. The methoxy-substituted
compounds DAMP and DIMP, had IC50s of 0.51 ± 0.13 and
1.9 ± 0.03 ,uM, respectively.
Within each homogeneous structural group, compounds
with an alkyl chain length of three carbons were generally
the most potent, followed by those with chain lengths of five
and six carbons. Each of the three most potent antigiardial
compounds had three methylenes in their alkyl chains. The
two- and four-carbon compounds generally exhibit de-
creased potency relative to the corresponding three-, five-,
and six-carbon compounds. The association between anti-
giardial activity and alkyl chain length is illustrated in Table
2, in which the length of the alkyl chain separating the
amidinophenoxy moieties varies from two to six methylenes.
Propamidine, the three-carbon compound (compound 2),
was approximately threefold more active than pentamidine
A
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FIG. 2. Graphic representation of the relationship between G. lamblia growth and [3H]thymidine uptake in the presence of test agents






TABLE 1. Antigiardial activities of compounds in clinical use versus those of the most potent dicationic compounds
Mean IC50 (1LM) ± SD'
Compound Structure for G. lamblia
HNz NH
Propamidine H2N NH2 1.7 ± 0.37
HNu 00-(CH2)-o_c(N_H<
DAMP OCH3 CH30 0.51 ± 0.13
CN 0--(CH2)3-0. N
DIMP H OCH3 30 H 1.9 ± 0.03
02N 0 CH=N
N O
Furazolidone t 1.0 ± 0.03
CH2CH20H
0N NyCH3
Metronidazole \N 2.1 ± 0.80
CH3
NHCH(CHAN(C2H5)2. 2HCI
Quinacrine HCI cI. <2 0.03 ± 0.02
CH2CH2SO2CH2CH3
02N N ~(cH3
Tinidazole tt 0.78 ± 0.48
a Values are the means for two separate determinations for each compound (two serial dilutions per determination) ± the standard deviations.




Compound no. n Mean IC50 (GLM) ± SD' Mean DNA binding (ATm [°C]) ± SDb ClogPfor G. lamblia Calf thymus DNA Poly(dA) poly(dT) Poly(dG-dC) poly(dG-dC)
1 2 280 ± 3.3 5.4 ± 0.2 7.5 ± 2.6 1.3 ± 0.03 3.3
2 3 1.7 ± 0.37 14.7 ± 1.7 32.0 ± 0.7 4.5 ± 0.2 3.5
3 4 16±0.45 8.3±2.5 17.9±1.6 3.1±0.4 4.0
4 5 8.5 ± 2.7c 10.7 ± 0.6 22.9 ± 0.7 3.2 ± 0.5 4.6
5 6 5.5 ± 1.4 9.1 ± 1.8 19.0 ± 0.6 2.9 ± 0.4 5.1
aValues are the means for two separate determinations for each compound (two serial dilutions per determination) ± the standard deviations.
b Values are the means for two to four separate determinations ± the standard deviations (5a, 41).
c Value is the mean for six separate determinations for pentamidine (two serial dilutions per determination) ± the standard deviation.
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TABLE 3. Biological activities of x,w-di(3-amidinophenoxy)alkanes
N NH(CH2)n2 NH
HN`f\H NH2 NH2 N
Compound no. n Mean IC50 (GM) ± SE' Mean DNA binding (ATm [°C]) ± SDb ClogPfor G. lamblia Calf thymus DNA Poly(dA) poly(dT) Poly(dG-dC) poly(dG-dC)
6 3 99 ± 0.66 7.6 ± 1.1 8.5 ± 0.5 3.0 ± 0.4 3.5
7 4 21 ± 5.2 8.1 ± 0.6 15.2 ± 1.4 2.6 0.2 4.0
8 5 11 ± 2.6 7.6 ± 0.6 7.6 ± 1.5 2.2 0.2 4.6
9 6 6.7 ± 0.95 7.3 ± 0.5 8.1 ± 0.6 2.5 ± 0.5 5.1
a Values are the means for two separate determinations for each compound (two serial dilutions per determination) + the standard deviations.
b Values are the means for two to four separate determinations ± the standard deviations (5a, 41).
(compound 4). Hexamidine (compound 5), the six-carbon the meta-amidinophenoxy compounds, with an IC50 of 6.7 ±
analog, was similar in activity to pentamidine (compound 4), 0.95 ,uM.
while the two (compound 1)- and four (compound 3)-carbon The antigiardial activities of analogs in which five different
compounds were much less potent. The meta-amidinophe- substituents were placed ortho to the ether bridge on both
noxy compounds (Table 3) were notable exceptions to this aromatic rings are shown in Table 4. As with the unsubsti-
generalization. tuted compounds (Table 2), compounds with alkyl chains of
The effect of shifting the amidino group on the aromatic three and five carbons appeared to be more active than the
ring from the position para to the ether bridge to a meta corresponding two- and four-carbon derivatives. The most
position is shown in Table 3. In this group of compounds, interesting compounds of this group are those in which
improved potency was observed with addition of methylenes methoxy groups were placed upon the aromatic rings (com-
to the alkyl bridges separating the amidino-phenoxy moi- pounds 16 to 18). This substitution produced compounds
eties. The three-carbon alkyl chain analog (compound 6) with increased antigiardial activities relative to the unsubsti-
exhibited the least antigiardial activity, with an IC50 of 99 ± tuted compounds (compounds 2 to 4). The three-carbon
0.66 ,uM, over 50-fold less active than propamidine (com- alkyl-chain methoxy-substituted analog DAMP (compound
pound 2), the corresponding para-amidinophenoxy com- 16), had an IC50 of 0.51 ± 0.13 ,uM and was the most active
pound. The six-carbon meta-amidinophenoxy compound dicationic compound screened in this study. Addition of
(compound 9) exhibited the greatest antigiardial activity of nitro (compounds 10 to 12) and amino (compounds 13 to 15)





Compound no. n X Mean IC50 (GM) + S Mean DNA binding [ ClogPfor G. lamblia Calf thymus DNA Poly(dA) poly(dT) Poly(dG-dC) poly(dG-dC)
10 2 NO2 85 ± 11 5.6 ± 0.3 10.3 ± 0.2 1.9 ± 0.2 2.8
11 4 NO2 16 ± 0.30 9.6 ± 1.3 14.7 ± 0.5 3.5 ± 0.6 3.6
12 5 NO2 8.2 ± 5.5 9.7 ± 1.2 21.6 ± 1.7 3.2 ± 0.2 4.1
13 2 NH2 126 ± 0.30 8.8 ± 0.2 16.1 ± 0.9 3.0 ± 0.3 1.2
14 3 NH2 2.3 ± 1.4 13.6 ± 0.1 32.2 ± 0.7 5.2 ± 0.4 1.4
15 4 NH2 33 ± 1.6 9.6 ± 0.3 19.4 ± 2.3 3.7 ± 1.3 1.9
16 3 OCH3 0.51 ± 0.13 16.3 ± 0.1 36.3 ± 3.0 3.4 ± 0.4 2.6
17 4 OCH3 7.7 ± 1.6 10.2 ± 0.2 22.9 ± 0.9 1.1 ± 0.5 3.1
18 5 OCH3 2.9 ± 0.62 12.0 ± 0.7 27.2 ± 0.1 2.7 ± 0.1 3.6
19 4 Cl 10 3.9 8.9 0.6 20.3 0.5 4.2 0.6 5.2
20 5 Cl 2.9 ± 0.01 10.5 ± 0.4 24.3 ± 0.3 4.6 ± 0.51 5.7
21 5 Br 2.6 ± 0.38 11.6 ± 0.2 25.2 ± 0.2 5.2 ± 0.4 6.0
a Values are the means for two separate determinations for each compound (two serial dilutions per determination) ± the standard deviations.
b Values are the means for two to four separate determinations ± the standard deviations (5a, 41).
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TABLE 5. Biological activities of a,w-di(4-amidinoanilino)alkanes
Compound no. n X Mean IC50 (,M) ± SD' MeanDNA-binding (ATm[°C])±SDb ClogPfor G. lamblia Calf thymus DNA Poly(dA) poly(dT) Poly(dG-dC) poly(dG-dC)
22 3 H 3.1 ± 0.33 11.6 ± 0.9 25.7 ± 4.5 3.0 ± 0.2 2.7
23 4 H 12 2.7 10.3 0.8 18.7 ± 2.9 2.8 0.2 3.2
24 5 H 5.4 ± 0.38 11.3 ± 0.2 20.7 ± 0.3 4.4 ± 0.2 3.7
25 6 H 2.2 ± 0.51 9.1 ± 1.2 12.9 ± 1.1 2.9 + 1.1 4.3
26 3 NO2 5.9 + 3.9 12.4 ± 0.8 26.6 + 1.6 5.0 ± 0.6 2.2
27 5 NO2 5.0 + 1.6 12.7 ± 0.2 22.1 + 0.6 6.2 ± 0.6 3.3
28 2 NH2 440 ± 2.8 9.8 ± 0.5 16.8 ± 1.9 3.0 ± 0.4 0.2
29 4 NH2 36 ± 2.4 10.5 ± 0.7 13.2 ± 0.6 4.6 ± 0.4 0.7
30 5 NH2 16 ± 6.9 11.0 ± 0.1 20.9 ± 0.7 3.3 ± 0.4 1.3
31 6 NH2 7.2 ± 2.9 8.3 ± 0.6 15.0 ± 0.5 3.6 ± 1.9 1.8
a Values are the means for two separate determinations for each compound (two serial dilutions per determination) ± the standard deviations.
b Values are the means for two to four separate determinations ± the standard deviations (5a, 41).
groups on the aromatic rings did not significantly alter unsubstituted anilino compounds, while nitro substitution
antigiardial activity. Chloro (compounds 19 and 20)- and (compounds 26 and 27) did not greatly alter activity in
bromo (compound 21)-substituted compounds exhibited in- relation to the unsubstituted anilino compounds.
creased antigiardial activity relative to the corresponding Replacement of the amidino groups with imidazolino
unsubstituted compounds (compounds 3 and 4). moieties (Table 6) produced compounds with similar or only
The effect of isosteric replacement of the ether oxygens slightly altered activity against G. lamblia compared with the
with nitrogens upon antigiardial activity is reported in Table corresponding para-amidinophenoxy compounds (Table 2).
5. Except for the six-carbon amidinoanilino compound (com- Methoxy substitution of imidazolino compounds (com-
pound 25), the anilino compounds (compounds 22 to 25) pounds 35 to 37) had little or no effect on antigiardial activity
exhibited antigiardial activity approximately equal to that of relative to the corresponding imidazolino compounds or the
the corresponding phenoxy compounds (Table 2). The six- corresponding methoxy-substituted amidinophenoxy com-
carbon amidinoanilino compound (compound 25) was over pounds. Methylation of the imidazolino nitrogens produced
twofold more active than hexamidine (compound 5), the compounds (compounds 38 and 39) with greatly reduced
corresponding amidinophenoxy analog. Amino substitution antigiardial activities. The antiprotozoal activities of these
of anilino compounds (compounds 28 to 31) resulted in a imidazolino compounds are especially important, because it
slight decrease in antigiardial activity compared with the has been suggested that diamidino compounds have antipro-
TABLE 6. Biological activities of ct,w-di(4-imidazolinophenoxy)alkanes
LZ> -Q Co-(CH2).-O Q 0
Y X x y
Compound no. n X Y Mean IC50 (,uM) ± SD' Mean DNA binding (ATm [°C]) ± SD" ClogPfor G. lamblia Calf thymus DNA Poly(dA) poly(dT) Poly(dG-dC) poly(dG-dC)
32 3 H H 3.1 1.2 12.7 ± 0.6 26.9 ± 0.4 4.8 ± 0.4 5.6
33 4 H H 8.2 ± 1.8 12.0 ± 0.1 15.6 ± 0.6 4.8 ± 0.04 6.1
34 5 H H 5.7 1.7 10.5 ± 0.7 22.1 ± 0.6 4.8 ± 0.6 6.6
35 3 OCH3 H 1.9 ± 0.03 13.1 ± 1.9 30.4 ± 3.7 3.7 ± 1.5 4.6
36 4 OCH3 H 9.8 ± 1.1 10.1 ± 0.15 22.7 ± 0.2 3.9 ± 0.5 5.1
37 5 OCH3 H 5.4 ± 1.3 10.4 ± 1.5 22.4 ± 0.3 4.6 ± 0.2 5.7
38 4 H CH3 110 ± 28 7.2 ± 0.1 4.1 ± 0.1 1.5 ± 0.4 7.9
39 5 H CH3 78 ± 0.19 5.6 ± 1.9 10.0 ± 0.2 3.4 ± 0.1 8.4
a Values are the means for two separate determinations for each compound (two serial dilutions per determination) ± the standard deviations.
b Values are the mean for two to four separate determinations ± the standard deviations (5a, 41).
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tease activity (15). While amidinophenoxy compounds are
effective inhibitors of trypsin (15, 41), imidazolino com-
pounds are devoid of antitrypsin activity and yet are active
against G. lamblia, Leishmania mexicana amazonensis (2),
and Plasmodium falciparum (2) in vitro and Pneumocystis
carinii (22) in vivo.
DNA binding affinity and its correlation to antigiardial
activity. By using the mean IC50s of these compounds against
G. lamblia and the mean affinity of these compounds to calf
thymus DNA, poly(dA) - poly(dT), and poly(dG-dC)- poly
(dG-dC), it was possible to determine correlations between
antigiardial activities and the affinities of these compounds
for DNA. The structure-activity relationships are repre-
sented by the following equations:
-logIC50 = -4.21 + 0.20 (±0.02)CT + 0.19 (+0.05)n
+ 0.11 (+0.03)ClogP - 0.78 (40.27)I(CH3)
(n = 39, r2 = 0.81, F = 36.7, s = 0.30)
-logIC50 = -3.46 + 0.06 (±0.01)AT + 0.22 (±0.05)n
+ 0.08 (+0.04)ClogP - 0.62 (+0.29)1(CH3)
(n = 39, r2 = 0.80, F = 34.9, s = 0.31)
-logIC50 = -2.57 + 0.18 (±0.08)GC + 0.15 (±0.08)n
+ 0.09 (+0.06)ClogP - 1.26 (±0.47)ICH3)
(n = 39, r2 = 0.43, F = 6.5, s = 0.52)
where n is the sample number; r2 is variance; F is the F test;
s is the standard error of the estimate; IC50 is in ,uM; calf
thymus DNA, poly(dA) poly(dT), and poly(dG-dC). poly
(dG-dC) are represented by CT, AT, and GC, respectively; n
is the length of the alkyl bridge connecting the amidinophe-
noxy moieties; ClogP is a calculated value for the transport
of the molecules across an octanol-water partition; and I(CH3)
is an indicator variable to note the presence of methyl groups
upon the imidazolino moieties (compounds 37 and 38). These
variables allowed calculation of the r2 values for the corre-
lation of antigiardial activity with calf thymus DNA, poly
(dA) poly(dT), and poly(dG-dC) - poly(dG-dC). There was
a strong correlation between antigiardial activities and the
affinities of these compounds for calf thymus DNA (r2 =
0.81) and poly(dA) poly(dT) (r2 = 0.80) and a much lower
correlation between antigiardial activities and the affinities of
the compounds for poly(dG-dC) poly(dG-dC) (r2 = 0.43).
All of these compounds exhibited affinity for calf thymus
DNA, poly(dA) - poly(dT), and poly(dG-dC) - poly(dG-dC)
in the thermal denaturation assay. In all but two cases,
compounds 8 and 38, the data suggest that these compounds
showed higher affinities for poly(dA) poly(dT) than for calf
thymus DNA. These compounds also appeared to exhibit
higher affinities for calf thymus DNA and poly(dA). poly
(dT) than for poly(dG-dC) - poly(dG-dC). The ATms ranged
from 5.4 + 0.2 to 16.3 + 0.1°C and from 7.5 + 2.6 to 36.3 +
3.0°C for calf thymus DNA and poly(dA) - poly(dT), respec-
tively. The affinity for poly(dG-dC) poly(dG-dC) did not
seem to alter as greatly within each homogeneous structural
group, and ATms for poly(dG-dC) * poly(dG-dC) ranged from
1.1 ± 0.5 to 6.2 + 0.6°C. For these reasons and because
there was no strong correlation between antigiardial activi-
ties and the affinities of the compounds for poly(dG-dC)
poly(dG-dC), these data will not be considered in detail.
Compounds with alkyl chain lengths of three or five
carbons showed greater affinities for DNA than did those
with alkyl chain lengths of two, four, or six carbons. Within
homogeneous structural groups, the three-carbon com-
pounds showed the greatest affinities for calf thymus DNA
and poly(dA) - poly(dT). This is illustrated in Table 2, in
which the three-carbon compound propamidine (compound
2) exhibited ATms of 14.7 ± 1.7 and 32.0 ± 0.7°C for calf
thymus DNA and poly(dA) poly(dT), respectively. An ex-
ception to this generalization are the meta-amidinophenoxy
compounds (Table 3), which showed reduced affinity for calf
thymus DNA and poly(dA) poly(dT) relative to the corre-
sponding para-amidinophenoxy compounds, and the two
compounds in which methylene groups have been placed
upon the imidazolino moieties (compounds 38 and 39).
In general, placing substituent groups upon the aromatic
rings ortho to the ether bridge (Table 4) slightly improved or
did not greatly alter the affinities of the compounds for calf
thymus DNA and poly(dA) - poly(dT). DAMP, the com-
pound with the most pronounced antigiardial activity (com-
pound 16), also exhibited the strongest affinities for calf
thymus DNA and poly(dA) poly(dT), with ATms of 16.3 ±
0.1 and 36.3 ± 3.0°C, respectively. Isosteric replacement of
the ether oxygens with nitrogens (compounds 22 to 25) did
not greatly change the affinities of the compounds for calf
thymus DNA and poly(dA) - poly(dT) relative to those of the
corresponding amidinophenoxy compounds (compounds 2
to 5). Nor did placement of nitro and amino groups upon the
aromatic rings of the amidinoanilino compounds greatly alter
their affinities for calf thymus DNA or poly(dA) poly(dT)
(compounds 26 to 31). Likewise, replacement of the amidino
groups with imidazolino moieties (Table 6) had little effect on
the affinity of the compounds for calf thymus DNA and/or
poly(dA) poly(dT) relative to the corresponding amidi-
nophenoxy compounds (compounds 2 to 4 and 16 to 18).
Methylation of the nitrogens on the imidazolino moiety
produced compounds (compounds 38 and 39) with greatly
reduced affinities for both calf thymus DNA and poly(dA).
poly(dT) relative to those of the corresponding amidinophe-
noxy compounds (compounds 3 and 4).
DISCUSSION
Current interest in the development of new pentamidine
analogs has been spurred by the increase in P. carinii
pneumonia associated with the acquired immune deficiency
syndrome. This epidemic has led to extensive investigations
to identify more potent, less toxic analogs of pentamidine for
treatment of this and other parasitic infections. The com-
pounds described in this study and similar analogs have been
tested in the rat model of P. carinii pneumonia (22, 41, 42).
Preliminary data suggest that many of these compounds are
more potent against P. carinii pneumonia and less toxic than
the parent compound (22, 41, 42). These compounds have
also been found to have activity in vitro against P. falci-
parum and L. mexicana amazonensis (2). The data described
in the current study reveal that G. lamblia trophozoites are
susceptible to strongly dicationic diamidines and di-imidazo-
lines. Further, these data confirm previously published re-
ports showing the radiometric assay to be a valid, reproduc-
ible, and sensitive method for assessment of the antigiardial
activities of therapeutic agents in a microculture system (3,
19). The strong correlation between antigiardial activities
and the affinities of these compounds for calf thymus DNA
and poly(dA) poly(dT) suggests that DNA binding is a
mechanism by which these compounds exert antigiardial
activity. In addition, the antigiardial activities of some of the
compounds tested in this study compared favorably with
those of the drugs currently used to treat giardiasis.
Aromatic diamidines have not been previously reported to
be active against G. lamblia trophozoites. Given the side-
effects and treatment failures associated with the compounds
currently used to treat giardiasis, it is obvious that more
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efficacious and less toxic drugs could have clinical applica-
tions in the treatment of this infection. This study has
identified three compounds with promising activity against
G. lamblia in vitro, each of which has a three-carbon alkyl
chain. DAMP (compound 16) was the most potent pentami-
dine analog identified in this study and is also significantly
more potent than pentamidine against P. carinii pneumonia
in the rat model of disease at one-half of the dosage of the
parent compound (41). Propamidine (compound 2) and
DIMP (compound 35) were also very active against G.
lamblia. DIMP (compound 35) has demonstrated 10 times
the activity of pentamidine against P. carinii pneumonia in
the rat model of disease and is active upon oral administra-
tion (22).
The potency of the three-carbon pentamidine analogs
against G. lamblia illustrates an important factor in the
structure-activity relationships of these compounds. That is,
the number of methylenes in the alkyl chain separating the
amidinophenoxy moieties is an important factor in both their
antiprotozoal activity and their affinity for calf thymus DNA
and poly(dA) - poly(dT). Compounds with three, five, or six
methylenes in their alkyl chains are generally more potent
against G. lamblia than those with two- or four-carbon alkyl
chains. The relationship between chain length and antipro-
tozoal activity was also observed when these compounds
were tested in vitro against L. mexicana amazonensis and P.
falciparum (2). Except for the meta-amidinophenoxy com-
pounds, analogs with alkyl chains consisting of odd numbers
of carbons also exhibited higher affinities for calf thymus
DNA and poly(dA) * poly(dT) than did compounds with
even numbers of carbons in their alkyl chains. The three
most potent compounds (compounds 2, 16, and 35) each
have alkyl chains consisting of three methylenes and are
among the best DNA-binding agents. Additionally, the great
reduction in antigiardial activity produced when methylene
groups are placed upon the imidazolino moieties corre-
sponds to a greatly reduced affinity of these compounds for
calf thymus DNA and poly(dA) poly(dT).
The strong correlation between antigiardial activity and
drug affinity for poly(dA) * poly(dT) and the poor correlation
between antigiardial activity and drug affinity for poly(dG-
dC) * poly(dG-dC) may be explained by the sequence spec-
ificity exhibited by diamidines in their binding to DNA.
Diamidines such as pentamidine, 4',6-diamidino-2-phenylin-
dole, and berenil have been shown to bind preferentially to
A+T-rich regions in minor grooves of B-DNA without
intercalating between base pairs (12, 28, 32, 34, 38). The
preferential binding of diamidino compounds to A+T-rich
regions is further confirmed by the disruption of A+T-rich
kinetoplastic DNA in leishmania (7) and trypanosomes (33).
The DNA-binding abilities of these agents may not, how-
ever, be their primary mechanism of action. 4',6-Diamidino-
2-phenylindole has been shown to inhibit the activity of a
type II topoisomerase (46), and it has been suggested that
pentamidine also inhibits a type II topoisomerase of trypano-
somes (40). Thus, DNA binding might be important in the
activity of these agents in that binding to DNA brings them
into proximity to enzymes, such as topoisomerases, which
are involved in DNA synthesis and/or metabolism.
This study has identified a new class of agents with in vitro
activity against G. lamblia and has contributed to a better
understanding of the structure-activity relationships of ana-
logs of pentamidine and the possible mechanism(s) by which
these compounds exert their antimicrobial activities. It has
been determined that the number of methylenes in the alkyl
chain is important in both antigiardial activity and the affinity
of the compounds for DNA. The correlation between anti-
giardial activity and the affinities of these compounds for
both natural and synthetic DNAs suggests that DNA binding
is important in the antimicrobial action of these agents. The
information obtained from this study may aid in the design of
more potent and less toxic antiprotozoal agents which are
needed because of the continuing emergence of drug-resis-
tant parasites. Further, G. lamblia provides a valuable new
model to assist in determining the mechanism(s) of action of
this important class of compounds.
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